Aprocitentan found efficacious in patients with resistant hypertension in Phase 3 study Dr. Kamal Kant Kohli26 May 2022 7:45 PM ISTAprocitentan is an investigational, oral, dual endothelin receptor antagonist designed to potently inhibit the binding of endothelin-1 (ET-1) to ETA...
All doses of Vortioxetine may prevent relapse in patients with major depressive disorder Dr. Shravani Dali5 April 2022 9:00 AM ISTAll doses of vortioxetine are effective for relapse prevention, in patients with remitted major depressive disorder, according to a recent study...
Use of adjunct intra-arterial alteplase beneficial in Patients with Acute Ischemic Stroke Dr. Shravani Dali23 March 2022 9:00 AM ISTAmong patients with large vessel occlusion acute ischemic stroke and successful reperfusion following thrombectomy, the use of adjunct ...
Risankizumab treatment may not benefit severe asthma patients finds NEJM study Dr. Shravani Dali8 Nov 2021 9:00 AM ISTPlacebo treatment was found to be superior to treatment with risankizumab with respect to time to first asthma worsening and annualized rate of...
Rivaroxaban & aspirin benefit PAD patients undergoing lower extremity revascularization: study Dr. Shravani Dali29 Oct 2021 9:45 AM ISTPatients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) benefit from low-dose rivaroxaban and aspirin ...
Hydrocortisone does not improve risk of death or bronchopulmonary dysplasia in preterm babies: JAMA Dr. Shravani Dali3 Aug 2021 10:00 AM ISTSystemic Hydrocortisone when initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants do not significantly improve the...
Azithromycin no better than placebo for COVID treatment, finds study Medical Dialogues Bureau20 July 2021 9:15 AM ISTLOS ANGELES: The commonly prescribed antibiotic for Covid-19, azithromycin, is no more effective than a placebo in preventing the viral disease among...
Zuranolone improves symptoms of Postpartum Depression, finds JAMA study Dr. Shravani Dali4 July 2021 9:15 PM ISTZuranolone (anti-depressive medication under the development of SAGE Therapeutics) when used in the treatment of postpartum depression was well...
Covid-19: With DCGI nod to revised protocol, Covovax Phase 3 trial to proceed without placebo Medical Dialogues Team7 Jun 2021 5:44 PM ISTPune: In a significant advance to the Serum Institute of India (SII), the Drugs Controller General of India (DCGI) has given its nod to approve the...
Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial Hina Zahid31 May 2021 8:00 AM ISTATS 2021, New York, NY - Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations...
Nivolumab effective treatment for malignant mesothelioma Hina Zahid16 Feb 2021 6:44 PM ISTSingapore - Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at...
Benvitimod cream: a new topical treatment for plaque psoriasis Hina Zahid20 Jan 2021 6:15 PM ISTPsoriasis is a chronic inflammatory skin disease characterized by erythematous (red) patches and plaques. In some patients, psoriasis may be...
